Compare UVSP & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVSP | CMPS |
|---|---|---|
| Founded | 1876 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 983.8M | 788.9M |
| IPO Year | 1994 | 2020 |
| Metric | UVSP | CMPS |
|---|---|---|
| Price | $33.34 | $6.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $35.00 | $27.14 |
| AVG Volume (30 Days) | 106.7K | ★ 4.4M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 21.32 | 0.86 |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $328,056,000.00 | N/A |
| Revenue This Year | $11.65 | N/A |
| Revenue Next Year | $4.77 | N/A |
| P/E Ratio | $10.54 | ★ N/A |
| Revenue Growth | ★ 9.64 | N/A |
| 52 Week Low | $24.22 | $2.25 |
| 52 Week High | $36.20 | $8.90 |
| Indicator | UVSP | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 48.28 |
| Support Level | $32.32 | $5.95 |
| Resistance Level | $35.83 | $7.02 |
| Average True Range (ATR) | 0.98 | 0.54 |
| MACD | -0.21 | -0.09 |
| Stochastic Oscillator | 33.97 | 17.01 |
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.